Publicaciones en las que colabora con JONÁS SAMUEL PÉREZ BLANCO (28)

2023

  1. Validation and clinical evaluation of an ultra-performance liquid chromatography with ultraviolet detector method for plasma quantification of micafungin

    Annals of Clinical Biochemistry, Vol. 60, Núm. 3, pp. 191-198

2022

  1. External evaluation of population pharmacokinetic models of imatinib in adults diagnosed with chronic myeloid leukaemia

    British Journal of Clinical Pharmacology, Vol. 88, Núm. 4, pp. 1913-1924

  2. Model-Informed Precision Dosing (MIPD)

    Pharmaceutics

  3. Physiologically-based pharmacokinetic modelling and dosing evaluation of gentamicin in neonates using PhysPK

    Frontiers in Pharmacology, Vol. 13

  4. Population Pharmacokinetics of Valproic Acid in Pediatric and Adult Caucasian Patients

    Pharmaceutics, Vol. 14, Núm. 4

  5. Population pharmacokinetics of a posaconazole tablet formulation in transplant adult allogeneic stem cell recipients

    European Journal of Pharmaceutical Sciences, Vol. 168

2021

  1. Evaluation of current amikacin dosing recommendations and development of an interactive nomogram: The role of albumin

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-13

2020

  1. Amikacin initial dosage in patients with hypoalbuminaemia: an interactive tool based on a population pharmacokinetic approach

    The Journal of antimicrobial chemotherapy, Vol. 75, Núm. 8, pp. 2222-2231

  2. Biomarkers of disease activity and other factors as predictors of adalimumab pharmacokinetics in inflammatory bowel disease

    European Journal of Pharmaceutical Sciences, Vol. 150

  3. Farmacocinética poblacional de fenitoína en pacientes adultos

    Farmajournal, Vol. 5, Núm. 2, pp. 15-26

  4. Population Pharmacokinetics of Apalutamide and its Active Metabolite N-Desmethyl-Apalutamide in Healthy and Castration-Resistant Prostate Cancer Subjects

    Clinical Pharmacokinetics, Vol. 59, Núm. 2, pp. 229-244

2019

  1. Evaluation of renal function equations to predict amikacin clearance

    Expert Review of Clinical Pharmacology, Vol. 12, Núm. 8, pp. 805-813

2018

  1. Diseño de un modelo poblacional para la monitorización farmacocinética de infliximab en enfermedad inflamatoria intestinal

    Farmajournal, Vol. 3, Núm. 1, pp. 77-85

2017

  1. Monitorización de digoxina en pacientes ancianos

    Farmajournal, Vol. 2, Núm. 1, pp. 21-29

  2. Pharmacokinetics and dosing requirements of digoxin in pregnant women treated for fetal supraventricular tachycardia

    Expert Review of Clinical Pharmacology, Vol. 10, Núm. 8, pp. 911-917

2016

  1. I Mesa Redonda de Becarios de la Facultad de Farmacia de Salamanca: Cómo continuar la carrera investigadora tras el doctorado

    Farmajournal, Vol. 1, Núm. 1, pp. 153-156

  2. Population pharmacokinetics of doxorubicin and doxorubicinol in patients diagnosed with non-Hodgkin's lymphoma

    British Journal of Clinical Pharmacology, Vol. 82, Núm. 6, pp. 1517-1527

  3. Usalpharma: A Software Architecture to Support Learning in Virtual Worlds

    Revista Iberoamericana de Tecnologias del Aprendizaje, Vol. 11, Núm. 3, pp. 194-204

2014

  1. Facility-based inspection training in a virtual 3D laboratory

    Accreditation and Quality Assurance, Vol. 19, Núm. 5, pp. 403-409

  2. Monitoring and feedback of learning processes in virtual worlds through analytics architectures: A real case

    Iberian Conference on Information Systems and Technologies, CISTI